Why the study?
Data evaluating remnant cholesterol and subsequent cardiovascular risk specifically in patients with premature acute coronary syndrome remain limited.
Does high remnant cholesterol predict major adverse cardiovascular and cerebrovascular events in patients with premature acute coronary syndrome?
Does high remnant cholesterol predict major adverse cardiovascular and cerebrovascular events in patients with premature acute coronary syndrome?
Elevated remnant cholesterol is associated with a significantly increased risk of major adverse cardiovascular and cerebrovascular events in patients with premature acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
May aid risk stratification in premature ACS; leaves open whether lowering remnant cholesterol reduces events.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: